Adalimumab/etanerceptLatent tuberculosis infection: 7 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2013年 / 1444卷 / 1期

关键词：

D O I：

10.1007/s40278-013-2024-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：6 / 6

相关论文

共 50 条

[31] Adalimumab/etanercept/infliximabPulmonary and extrapulmonary tuberculosis: 6 case reports
Reactions Weekly, 2015, 1570 (1) : 16 - 16
[32] Adalimumab/etanerceptInflammatory bowel disease: 7 case reports
Reactions Weekly, 2008, 1197 (1) : 5 - 5
[33] Adalimumab/azathioprine/infliximab/methotrexateTuberculosis: 7 case reports
Reactions Weekly, 2015, 1538 (1) : 15 - 15
[34] Adalimumab/etanercept/infliximabPityriasis versicolor: 7 case reports
Reactions Weekly, 2012, 1425 (1) : 6 - 6
[35] Adalimumab/infliximabPulmonary and disseminated Mycobacterium tuberculosis infection with pulmonary, hepatic and splenic involvement: 2 case reports
Reactions Weekly, 2017, 1645 (1) : 21 - 21
[36] Adalimumab/etanercept/infliximabOsteomyelitis, psoriasis and pulmonary tuberculosis: 3 case reports
Reactions Weekly, 2017, 1668 (1) : 24 - 24
[37] Adalimumab/isoniazidElevated liver transaminases and active tuberculosis: 2 case reports
Reactions Weekly, 2018, 1704 (1) : 20 - 20
[38] Adalimumab/methotrexatePulmonary tuberculosis and rise in transaminase levels: 2 case reports
Reactions Weekly, 2018, 1697 (1) : 19 - 19
[39] Adalimumab/infliximabMycobacterial tuberculosis and systemic lupus erythematosus : 4 case reports
Reactions Weekly, 2022, 1925 (1) : 24 - 24
[40] Adalimumab/etanercept/infliximabLate-onset tuberculosis?: 6 case reports
Reactions Weekly, 2009, 1260 (1) : 5 - 5

← 1 2 3 4 5 →